Pharmaceutical composition of apixaban
US11510909B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2018 |
| Grant date | Nov 29, 2022 |
| Priority date | — |
| Expiry date | Feb 5, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a stable, reproducible and bioequivalent apixaban compositions, wherein the composition comprising apixaban having a D90 particle size of more than 100 microns, preferably between 300 and 1000 microns, and more preferably between 350 and 800 microns, and further comprising one or more pharmaceutically acceptable excipients. The present disclosure further provides a process for preparation of a pharmaceutical composition comprising apixaban by wet granulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.